Cargando…
Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma
Osteosarcoma (OS) is the most common type of primary malignant bone tumor. The high-throughput sequencing technology has shown potential abilities to illuminate the pathogenic genes in OS. This study was designed to find a powerful gene signature that can predict clinical outcomes. We selected OS ca...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786962/ https://www.ncbi.nlm.nih.gov/pubmed/35075228 http://dx.doi.org/10.1038/s41598-022-05341-5 |